Elias Eythorsson, Hrafnhildur Linnet Runolfsdottir, Ragnar Freyr Ingvarsson, Martin I. Sigurdsson, and Runolfur Palsson.
August 3, 2022
JAMA Network Open
The National University Hospital of Iceland

"Methods

... This population-based cohort study monitored all persons previously infected with SARS-CoV-2 for reinfection during the Omicron wave in Iceland...

Discussion

In this population-based cohort study, a substantial proportion of persons experienced SARS-CoV-2 reinfection during the first 74 days of the Omicron wave in Iceland, with rates as high 15.1% among those aged 18 to 29 years. Longer time from initial infection was associated with a higher probability of reinfection, although the difference was smaller than expected. Surprisingly, 2 or more doses of vaccine were associated with a slightly higher probability of reinfection compared with 1 dose or less... Our results suggest that reinfection is more common than previously thought."

document
COVID-19,natural immunity,vaccines